Astellas Pharma Europe B.V.
Meppel - Drenthe
Astellas Pharma Europe B.V.
Vervaardiging van farmaceutische producten (geen grondstoffen)
100-499 wn.
Adres verborgen. Dit bedrijf wil geen ongevraagde postreclame of verkoop aan de deur.
01 04 05 08 1 100 2 20 2005 2015 2019 2021 2022 30 a about accept acces access accessibility acquisition act addres administered advances advertisement advic agreement all and anemia any are as astellas availabl barrier based be better betwen bottom brochur brow busines by call called carer challeng challenges check clas co common company conferenc connection considered contact contain contained content continue cookies corporat countries creation csp2021 d development dialysis different difficulty direct disaster dosages drug due employes enter established evaluation evolution evrenzo expanded financial financial/non-financial first first-in-clas follow footer for fujisawa general generat has hav header health healthcar her herein hif hif-ph history hom however important inc includ indication information inhibitor initiatives insufficient integrated intended into investor ir japan lack latest launch ltd mad many map material may media medical medicin medicines menu merger modern mor mrna mrna-based ned new next nor not nothing notic nov now oct on ones or orally organ other our pag pantherna partner path patient pc pdf peopl ph pharma pharmaceutical physician plan pleas policy posted potential poverty pres presentation privacy product profil program progres promotion provid provided provider published purpos r read regenerativ releases remain renal report report2022 reprogramm research result rich roxadustat scienc search secur sep should sit slavery slides social solicitation spanning still stored stories story strategic strategy strengthen substitut sustainability sustainabl system tablet target technology term that the ther they this through to trademark treatment under unmet us use used using value vol we web websit who with worldwid yamanouchi year you your
Vind meer informatie over Astellas Pharma Europe B.V. in de interactieve versie